Grazoprevir/elbasvir is the company's investigational NS3/4A protease ...
—Dr Sudhanshu Vrati, Dean, Translational Health Science &am...
Study published in the Journal of Neuroscience by a group of scientist...
A study conducted by the Center for Science and Environment (CSE), Ind...
AstraZeneca has announced that the European Commission (EC) has grante...
During their recent visit to India, Australian lifesciences and health...
Denovo Biopharma has acquired enzastaurin, a late-stage oncology drug,...
Zydus Cadila has launched biosimilar of Adalimumab, used for the treat...
The prize winners will include eminent people hailing from various cat...
Novartis India announced the next edition of the Novartis Biotechnolog...
E-Meditek Global (the holding company of E-Meditek TPA, a leading Thir...
To mark Sub-National Immunization day (SNID) children's 5 years and be...
The sale of its clinical manufacturing operations (CMO) in Nantes to B...
The study by Imperial College, London, and the Christian Medical Colle...
According to a recent Frost & Sullivan report, the oncology market...
As nearly 3.2 billion people continue to live in areas with risk of ma...
"We need to hear the voices of those who think technology has somethin...
Global biopharmaceutical company, Baxter International, is recalling o...
